Literature DB >> 16428796

Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG.

H Martin Vordermeier1, Kris Huygen, Mahavir Singh, R Glyn Hewinson, Zhou Xing.   

Abstract

Cattle were vaccinated with an adenovirus expressing the mycobacterial antigen 85A (rAd85A), with Mycobacterium bovis BCG followed by rAd85A heterologous boosting, or with rAd85A followed by BCG boosting. BCG/rAd85A resulted in the highest direct gamma interferon responses. Cultured enzyme-linked immunospot assay analysis demonstrated that memory responses were induced by all three protocols but were strongest after BCG/rAd85A and rAd85A/BCG vaccination.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16428796      PMCID： PMC1360309          DOI： 10.1128/IAI.74.2.1416-1418.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  18 in total

1.  Lineage relationship and protective immunity of memory CD8 T cell subsets.

Authors:  E John Wherry; Volker Teichgräber; Todd C Becker; David Masopust; Susan M Kaech; Rustom Antia; Ulrich H von Andrian; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-02-03       Impact factor: 25.606

2.  Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.

Authors:  H McShane; R Brookes; S C Gilbert; A V Hill
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.

Authors:  Lise Brandt; Joana Feino Cunha; Anja Weinreich Olsen; Ben Chilima; Penny Hirsch; Rui Appelberg; Peter Andersen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

Authors:  H Martin Vordermeier; Mark A Chambers; Paul J Cockle; Adam O Whelan; Jennifer Simmons; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.

Authors:  Michael Santosuosso; Xizhong Zhang; Sarah McCormick; Jun Wang; Mary Hitt; Zhou Xing
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

6.  Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus.

Authors:  Andrew J Godkin; Howard C Thomas; Peter J Openshaw
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

7.  A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

Authors:  Margot A Skinner; Bryce M Buddle; D Neil Wedlock; Denise Keen; Geoffrey W de Lisle; Ricardo E Tascon; Jose Candido Ferraz; Douglas B Lowrie; Paul J Cockle; H Martin Vordermeier; R Glyn Hewinson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.

Authors:  Nilu P Goonetilleke; Helen McShane; Carolyn M Hannan; Richard J Anderson; Roger H Brookes; Adrian V S Hill
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

Review 9.  Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.

Authors:  R G Hewinson; H M Vordermeier; B M Buddle
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

10.  A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.

Authors:  William H H Reece; Margaret Pinder; Philip K Gothard; Paul Milligan; Kalifa Bojang; Tom Doherty; Magdalena Plebanski; Peter Akinwunmi; Simone Everaere; Katherine R Watkins; Gerald Voss; Nadia Tornieporth; Ali Alloueche; Brian M Greenwood; Kent E Kester; Keith P W J McAdam; Joe Cohen; Adrian V S Hill
Journal:  Nat Med       Date:  2004-03-14       Impact factor: 53.440
View more
  26 in total

1.  Mucosal immunization provides better protection than subcutaneous immunization against Pasteurella multocida (B:2) in mice preimmunized with the outer membrane proteins.

Authors:  Subhash Kharb; Shiv Charan
Journal:  Vet Res Commun       Date:  2011-06-02       Impact factor: 2.459

2.  Improved skin test for differential diagnosis of bovine tuberculosis by the addition of Rv3020c-derived peptides.

Authors:  Gareth J Jones; Adam Whelan; Derek Clifford; Mick Coad; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

3.  Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.

Authors:  Michael Santosuosso; Sarah McCormick; Xizhong Zhang; Anna Zganiacz; Zhou Xing
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.

Authors:  Clare R Sander; Ansar A Pathan; Natalie E R Beveridge; Ian Poulton; Angela Minassian; Nicola Alder; Johan Van Wijgerden; Adrian V S Hill; Fergus V Gleeson; Robert J O Davies; Geoffrey Pasvol; Helen McShane
Journal:  Am J Respir Crit Care Med       Date:  2009-01-16       Impact factor: 21.405

Review 5.  Viruses as vaccine vectors for infectious diseases and cancer.

Authors:  Simon J Draper; Jonathan L Heeney
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

6.  Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle.

Authors:  Gareth J Jones; Sabine Steinbach; Derek Clifford; Susan L Baldwin; Gregory C Ireton; Rhea N Coler; Steven G Reed; H Martin Vordermeier
Journal:  Vaccine       Date:  2013-09-05       Impact factor: 3.641

7.  Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.

Authors:  Yushi Yao; Rocky Lai; Sam Afkhami; Siamak Haddadi; Anna Zganiacz; Fatemeh Vahedi; Ali A Ashkar; Charu Kaushic; Mangalakumari Jeyanathan; Zhou Xing
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens.

Authors:  Monica Cabrera-Mora; Jairo Andres Fonseca; Balwan Singh; Chunxia Zhao; Natalia Makarova; Igor Dmitriev; David T Curiel; Jerry Blackwell; Alberto Moreno
Journal:  J Immunol       Date:  2016-08-29       Impact factor: 5.422

9.  Screening of predicted secreted antigens from Mycobacterium bovis reveals the immunodominance of the ESAT-6 protein family.

Authors:  Gareth J Jones; Stephen V Gordon; R Glyn Hewinson; H Martin Vordermeier
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

10.  Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.

Authors:  Zhou Xing; Christine T McFarland; Jean-Michel Sallenave; Angelo Izzo; Jun Wang; David N McMurray
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.